Kite Pharma, Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-06-25: Reporting owner Kazam Joshua A; Form 4; Security Warrant to Purchase Common Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-06-25 | Kazam Joshua A Director | 4 | Warrant to Purchase Common Stock Derivative · Direct | C Conversion of derivative security | +40,000 40,000 owned after | $2.04 exercise price | 2014-06-27 |